Log In
Print this Print this

Invega Sustenna, Xeplion (paliperidone palmitate)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionIntramuscular injection of paliperidone, a metabolite of risperidone
Molecular Target Monoamine receptors
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSchizophrenia
Indication DetailsTreat schizoaffective disorder; Treat schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today